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Potentially serious incidental findings on brain and body  
magnetic resonance imaging of apparently asymptomatic adults: 
systematic review and meta-analysis
Lorna M Gibson,1 Laura Paul,2 Francesca M Chappell,3 Malcolm Macleod,3 William N Whiteley,3 
Rustam Al-Shahi Salman,3 Joanna M Wardlaw, 3 Cathie L M Sudlow1
ABSTRACT
OBJECTIVES
To determine prevalence and types of potentially 
serious incidental findings on magnetic resonance 
imaging (MRI) in apparently asymptomatic adults, 
describe factors associated with potentially serious 
incidental findings, and summarise information on 
follow-up and final diagnoses.
DESIGN
Systematic review and meta-analyses.
DATA SOURCES
Citation searches of relevant articles and authors’ files 
in Medline and Embase (from inception to 25 April 
2017).
REVIEW METHODS
Eligible studies included prevalence and types of 
incidental findings detected among apparently 
asymptomatic adults undergoing MRI of the brain, 
thorax, abdomen, or brain and body. Data on study 
population and methods, prevalence and types 
of incidental findings, and final diagnoses were 
extracted. Pooled prevalence was estimated by 
random effects meta-analysis, and heterogeneity by τ2 
statistics.
MAIN OUTCOME MEASURES
Prevalence of potentially serious incidental findings on 
MRI of the brain, thorax, abdomen, and brain and body.
RESULTS
Of 5905 retrieved studies, 32 (0.5%) met the 
inclusion criteria (n=27 643 participants). Pooled 
prevalence of potentially serious incidental findings 
was 3.9% (95% confidence interval 0.4% to 27.1%) 
on brain and body MRI, 1.4% (1.0% to 2.1%) on 
brain MRI, 1.3% (0.2% to 8.1%) on thoracic MRI, and 
1.9% (0.3% to 12.0%) on abdominal MRI. Pooled 
prevalence rose after including incidental findings 
of uncertain potential seriousness (12.8% (3.9% to 
34.3%), 1.7% (1.1% to 2.6%), 3.0% (0.8% to 11.3%), 
and 4.5% (1.5% to 12.9%), respectively). There was 
generally substantial heterogeneity among included 
studies. About half the potentially serious incidental 
findings were suspected malignancies (brain, 0.6% 
(95% confidence interval 0.4% to 0.9%); thorax, 0.6% 
(0.1% to 3.1%); abdomen, 1.3% (0.2% to 9.3%); 
brain and body, 2.3% (0.3% to 15.4%)). There were 
few informative data on potential sources of between-
study variation or factors associated with potentially 
serious incidental findings. Limited data suggested 
that relatively few potentially serious incidental 
findings had serious final diagnoses (48/234, 20.5%).
CONCLUSIONS
A substantial proportion of apparently asymptomatic 
adults will have potentially serious incidental 
findings on MRI, but little is known of their health 
consequences. Systematic, long term follow-up 
studies are needed to better inform on these 
consequences and the implications for policies on 
feedback of potentially serious incidental findings.
SYSTEMATIC REVIEW REGISTRATION
Prospero CRD42016029472.
Introduction
Magnetic resonance imaging (MRI) of the brain and 
body (that is, the brain, thorax, and abdomen) is 
increasingly used for clinical and commercial screening 
and for research, with several large scale, population 
based imaging initiatives ongoing around the world.1-5 
The detection of incidental findings unrelated to the 
purpose of the imaging6 is an inevitable consequence. 
Clinicians and researchers should therefore anticipate 
incidental findings and develop appropriate policies 
for managing them, taking into account their expected 
prevalence and clinical severity.7 Existing data on 
the prevalence of incidental findings from systematic 
reviews of MRI of one body region,8 patient populations 
undergoing MRI,9 or apparently asymptomatic people 
imaged by another modality,10 are not generalisable 
to brain and body MRI of apparently asymptomatic 
people. Here, asymptomatic people are defined as 
WHAT IS ALREADY KNOWN ON THIS TOPIC
Estimates of prevalence of incidental findings vary widely, and could be of 
limited value to practice because they often include non-serious incidental 
findings
Previous systematic reviews have focused on incidental findings detected on 
magnetic resonance imaging (MRI) of a single body region, patient populations 
undergoing MRI, or apparently asymptomatic people imaged using another 
modality
These estimates are not generalisable to brain and body MRI of apparently 
asymptomatic people (imaging that is increasingly conducted in large scale 
imaging research and screening settings)
WHAT THIS STUDY ADDS
In meta-analyses of published studies, pooled prevalence of potentially serious 
incidental findings on MRI of apparently asymptomatic people was 3.9% for 
brain and body (1.4% brain, 1.3% thorax, and 1.9% abdomen), and 12.8% 
(1.7%, 3.0%, 4.5%, respectively) when including incidental findings of uncertain 
potential seriousness
Around half of potentially serious incidental findings were suspected 
malignancies
Limited follow-up data suggest that most potentially serious incidental findings 
might not be clinically serious on follow-up, and further research is needed
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community dwelling individuals not selected for 
imaging on the basis of symptoms, risk factors, or 
disease.
The clinical severity of incidental findings ranges 
from non-serious (eg, simple renal cyst) to potentially 
life threatening (eg, some malignancies), but their 
nature and severity are often unclear. Diagnostic 
radiological imaging is tailored optimally to 
demonstrate (or exclude) pathologies relevant to a 
patient’s presentation. By contrast, since incidental 
findings are, by definition, unrelated to the imaging’s 
purpose,6 no imaging protocol is specifically designed 
to optimise firm diagnoses of these findings. Further 
specific clinical follow-up is therefore often needed to 
permit final clinical diagnoses of incidental findings.
Given that knowing about clearly non-serious 
incidental findings would be of limited potential 
benefit, we focus here on potentially serious incidental 
findings, defined as those findings indicating the 
possibility of a condition which, if confirmed, would 
carry a real prospect of seriously threatening life 
span, or of having a substantial effect on major body 
functions or quality of life.11 The development of well 
informed approaches to the management of such 
potentially serious incidental findings on brain and 
body MRI in apparently asymptomatic adults requires 
data on their prevalence and types, associated factors, 
and the resulting final diagnoses.
We therefore aimed systematically to review studies 
of brain, thorax, abdomen, and brain and body MRI 
to determine the prevalence and types of potentially 
serious incidental findings among apparently 
asymptomatic adults, describe factors associated with 
such findings, and determine what is known about 
the follow-up and final diagnoses of people with these 
findings. This study was motivated by—and mainly 
conducted during preparations for—the ongoing UK 
Biobank multimodal imaging study (including brain 
and body MRI) of 100 000 people.5
Methods
We registered the protocol for this review with 
Prospero,12 and archived data online.13
Data sources
We searched Medline and Embase from inception to 
25 April 2017 for references to studies in any language 
that reported the prevalence of incidental findings in 
apparently asymptomatic adults undergoing cardiac, 
abdominal, or brain and body MRI (supplementary 
methods 1). For brain MRI, we screened studies 
included in a published systematic review of incidental 
findings in apparently asymptomatic volunteers8 and 
updated the search to 25 April 2017 (supplementary 
methods 1). We searched authors’ files and forward 
and backwards citations of retrieved studies for further 
relevant studies.
Study selection
One author (LMG) screened all references for potentially 
eligible studies. A second author (LP) independently 
screened a random sample of 10% of references to 
assess the reliability of this process. Disagreements 
were resolved through discussion between these 
authors, with arbitration by a senior author (CLMS) if 
necessary. We retrieved full text articles of potentially 
eligible studies. One author (LMG) assessed articles for 
inclusion, and discussed uncertainties with a senior 
author (CLMS).
We defined apparently asymptomatic people as those 
who were not selected on the basis of any symptoms, 
risk factors, or disease; and who attended for studies 
on population based research imaging, for commercial 
or occupational screening, or as research controls. We 
excluded studies of patients (that is, people selected 
for a study based on symptoms, risk factors, or 
disease; or those admitted to or attending a healthcare 
facility for clinical diagnostic imaging); magnetic 
resonance angiography that only reported vascular 
incidental findings (due to limited generalisability); 
prespecified subgroups of incidental findings 
(which would underestimate the prevalence of other 
incidental findings); children (<18 years old). Studies 
not published in full were also excluded. If multiple 
publications arose from a study, we prioritised the 
primary review question of prevalence, and included 
data from the largest cohort.
Data extraction
One author (LMG) extracted data from all included 
studies on study population, study methods, and 
prevalence and types of all incidental findings using a 
pre-piloted, standardised data extraction spreadsheet. 
To assess the reliability of this process, a second author 
(LP) independently extracted data from a 10% random 
sample of studies. Disagreements were resolved 
through discussion between these authors.
Study and population characteristics
We extracted data on sample size, numbers of men and 
women, mean age and age range of participants, the 
country where the imaging was conducted (or, if not 
reported, the country of the first author’s institution), 
body region(s) imaged, and imaging setting (classified 
as either research (if participants were imaged during 
research studies) or non-research settings (imaging was 
performed in other contexts, including occupational 
imaging or commercial imaging)).
Study imaging and reporting methods of incidental 
findings
We extracted data on whether prevalence of incidental 
findings was assessed by reviewing magnetic resonance 
images or reports, the specialist field and number 
of those reporting images, blinding of reporters to 
information about the participants, the MRI sequences 
performed, and the dates when MRI was performed.
Data on incidental findings
We extracted data on the total number of 
participants with incidental findings, the total 
number of incidental findings, or both if available; 
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number of participants with multiple incidental 
findings; prevalence of incidental findings by age, 
sex, imaging sequence, reporter, or any other factor 
assessed for association with incidental findings; 
and all available data on follow-up investigations, 
treatment, and final diagnoses for studies in 
which all participants with incidental findings or a 
specified subtype or severity of incidental findings 
were followed-up systematically.
Classification of incidental findings and final 
diagnoses
To determine which incidental findings were 
potentially serious according to our definition,11 
we referred to a list of potentially serious and non-
serious incidental findings developed by UK Biobank, 
based on consultations with radiologists, published 
literature, and the German National Cohort’s 
methods14 (supplementary methods 2). For any 
incidental finding not on this list, we directly applied 
our definition of a potentially serious incidental 
finding. If we had insufficient published information 
to apply our definition, we used study definitions of 
severe incidental findings, accepting that these vary 
somewhat between studies.13 Potentially serious 
incidental findings were classified further as suspected 
malignancy (eg, masses), non-malignant, or possible 
indicators of malignancy (incidental findings which 
were not masses, but could be related to malignancy, 
such as pleural effusions (supplementary methods 3)). 
We classified final diagnoses as serious if they were 
likely to significantly threaten lifespan or have a major 
effect on quality of life or major body functions, and as 
not serious if this was not the case. Incidental findings 
or final diagnoses that could not be classified were 
described as “indeterminate.”
Risk of bias assessment
In the absence of a validated quality assessment tool 
for studies of the prevalence of incidental findings, 
we extracted data on study characteristics that might 
affect risk of bias (sample selection methods, blinding 
of reporters to information about the participants, the 
specialty and number of image readers, and whether 
data on incidental findings were generated from reads 
of images or extracted from reports), and planned 
to consider their potential influence on the results 
through a series of subgroup analyses.
Data synthesis
We meta-analysed studies with a random effects 
model,15 using maximum likelihood estimation 
methods16 and modelling within-study variance as 
binomial, to calculate pooled prevalence of potentially 
serious incidental findings and of suspected 
malignant incidental findings, separately for brain, 
thorax, abdomen, and brain and body MRI. For the 
pooled estimates, we calculated both 95% confidence 
intervals and 95% prediction intervals; prediction 
intervals indicate the range of true prevalence values 
expected in future studies.17 We used t scores (rather 
than the usual z score) to calculate 95% confidence 
intervals, generating conservative estimates and 
allowing comparison with our prediction intervals 
(which also use t scores). Region specific data 
from studies of brain and body MRI were included 
in the brain, thoracic, and abdominal MRI meta-
analyses. We derived data on thoracic incidental 
findings from studies of either cardiac or brain and 
body MRI or both. To obtain upper estimates of the 
prevalence of potentially serious incidental findings 
and of suspected malignant incidental findings, we 
performed sensitivity meta-analyses by adding the 
indeterminate incidental findings to the potentially 
serious incidental findings, and possible indicators 
of malignancy to the suspected malignant incidental 
findings. We calculated 95% confidence intervals 
for individual studies’ prevalence estimates using 
Clopper Pearson exact methods. 
We assessed statistical heterogeneity using τ2 
statistics, which provide a logit scale measure of 
between-study variance, represented in a more 
readily interpretable way by the 95% prediction 
intervals. All study level characteristics were initially 
considered as potential candidates for subgroup 
analyses, to explore reasons for heterogeneity of the 
prevalence of potentially serious incidental findings. 
However, we chose not to conduct subgroup analyses 
that were likely to be uninformative (eg, owing 
to missing data for a large proportion of studies 
or substantial imbalance in subgroup sizes). We 
performed subgroup analyses by including study 
characteristics as covariates in the meta-analyses.18 
Formal statistical tests for possible publication bias 
were not performed because their application is 
limited in meta-analyses where outcome is expressed 
as a proportion.19 20 We also decided not to conduct 
formal meta-analysis of data on the percentage of 
potentially serious incidental findings that resulted in 
serious final diagnoses (that is, the positive predictive 
value of potentially serious incidental findings), to 
avoid undue emphasis on the limited data available. 
Instead, we described available findings and 
calculated a rough estimate of this percentage by 
summing numerators and denominators across the 
few studies with relevant data.
We used Microsoft Excel 2013 for descriptive 
statistical analyses, StatsDirect 3.0.177 for calculating 
95% confidence intervals for individual studies, and 
SAS 9.4 PROC NLMIXED (www.sas.com) for meta-
analyses.
Patient involvement
Patients were not involved in the development or 
design of this study. The results of this study will be 
disseminated to the public by the investigators where 
possible.
Results
Two authors agreed on 99% of the duplicate screened 
reference selections, and 100% of the duplicate 
extracted data.
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Included studies
Of 5905 retrieved studies, 3221-52 met the inclusion 
criteria. These 32 studies included 27 643 participants 
(range 2-5800 participants, mean/median age range 
21-75 years, 14 037/27 643 (50.8%) men) imaged 
between 1985 and 2016 (supplementary figure 
1, supplementary table 1). The included studies 
comprised eight of brain and body MRI,21-28 22 of brain 
MRI,29-50 and two of cardiac MRI.51 52 No abdomen only 
studies were identified (supplementary table 1). 
Studies were performed in Europe (20 
studies,21-25 27-29 31 34 36 37 39-41 43 44 47 48 52 17 702 
participants), North America (six,30 35 38 46 50 51 5789), 
Asia (four,26 32 33 45 3576), and Australia (two,42 49 
576; supplementary table 1). All but three studies 
assessed images for incidental findings; one assessed 
imaging reports,49 and two did not report on this.32 47 
All studies involved radiologists, except for one in 
which a cardiologist reported incidental findings on 
cardiac MRI (supplementary table 1).52 In two studies, 
radiologists confirmed incidental findings detected by 
trained readers (defined as researchers with training to 
doctor of medicine level or training in neuropsychiatry) 
in one29 and MRI scan operators (not further defined) 
in the other.45
Imaging sequences
The vast majority of participants were imaged by 
scanners of 1.5 T or less (19 studies, 23 809/27 643 
(86.1%) participants).21-25 27 29-34 36 37 41 42 48 49 51 
However, seven studies (1556 (5.6%) participants) 
used 3.0 T scanners,26 28 39 40 43 50 52 two (370 (1.3%)) 
used 1.5 T in some participants and 3.0 T in others,44 45 
and four (1908 (6.9%)) did not report magnet strength 
(supplementary table 2).35 38 46 47 All but three brain 
MRI studies23 36 47 used T1 weighted imaging. One 
study used T1 weighted imaging in an unknown subset 
of participants.40 Of 10 thoracic MRI studies, eight used 
non-contrast whole thorax imaging (n=4817),21-28 
and five used cardiac specific sequences 
(n=4099).21 22 24 51 52 All abdominal MRI studies used 
T1 weighted imaging (supplementary table 2).
Risk of bias assessment
Only one study appeared to have imaged an unselected, 
random population sample (n=2500).21 Most of the 
remaining studies imaged selected samples or did not 
clearly report sampling methods. At least one radiologist 
reported all images in almost all studies; 14 studies 
(8199 (29.7%) participants)21-24 26-28 33 34 37 43 46 48 51 
had more than one reader for each set of images 
(supplementary table 1). Data on blinding of readers 
to participants’ characteristics were incomplete, with 
only 16 studies (19 617 (71.0%) 
participants)21 23 24 27 29 30 31 34 36 37 38 41 44 45 48 49 clearly 
reporting blinding of image readers to participant 
characteristics (supplementary table 1). We saw no 
direct within-study comparisons between radiologist 
and non-radiologist readers, between single and 
multiple readers, or between blinding and non-
blinding of readers to participants’ characteristics, to 
reliably inform on any potential biases such methods 
might have on the prevalence of potentially serious 
incidental findings.
Prevalence and types of potentially serious 
incidental findings
Although 14 studies21 24 25 27 31 32 34 36 37 38 41 43 50 51 
reported data on multiple incidental findings per 
participant, none provided the number of participants 
with more than one potentially serious incidental 
finding, or data to enable calculations of this number. 
We therefore based prevalence estimates on the 
assumption that no participant had more than one 
potentially serious incidental finding, recognising that 
very few participants may have more than one. The 
pooled prevalences of potentially serious incidental 
findings on brain, thoracic, abdominal, and brain and 
body MRI were 1.4% (95% confidence interval 1.0% to 
2.1%), 1.3% (0.2% to 8.1%), 1.9% (0.3% to 12.0%), 
and 3.9% (0.4% to 27.1%), respectively. When 
indeterminate incidental findings were included, 
pooled prevalence estimates increased to 1.7% 
(1.1% to 2.6%), 3.0% (0.8% to 11.3%), 4.5% (1.5% 
to 12.9%), and 12.8% (3.9% to 34.3%), respectively. 
Study specific prevalence estimates ranged widely, 
with correspondingly wide prediction intervals 
and τ2 values ranging from 0.8 to 5.7 (indicative of 
substantial variance between studies; fig 1 and fig 2, 
supplementary figure 2, and supplementary table 3).
Across body regions, suspected malignancies 
were the most common types of potentially serious 
incidental findings (accounting for roughly half of all 
such findings), with vascular findings also common 
on brain MRI (fig 3 and supplementary tables 4a-c). 
Pooled prevalence of potentially serious incidental 
findings suspected to be malignant were 0.6% (95% 
confidence interval 0.4% to 0.9%) on brain MRI, 0.6% 
(0.1% to 3.1%) on thorax MRI, 1.3% (0.2% to 9.3%) 
on abdomen MRI, and 2.3% (0.3% to 15.4%) on brain 
and body MRI. After possible indicators of malignancy 
were included, these prevalences were 0.6% (0.4% 
to 0.9%), 1.0% (0.2% to 5.4%), 1.6% (0.2% to 
10.9%), and 3.0% (0.4% to 20.4%), respectively 
(supplementary figure 2).
Subgroup analyses
Examination of the available data (supplementary 
tables 1 and 2) showed that several potential subgroup 
analyses would be uninformative owing to imbalanced 
subgroups or non-reporting of the relevant data for a 
large subset of studies. One or both of these reasons 
precluded subgroup analyses with respect to magnet 
strength (almost all 1.5 T), contrast use (incomplete 
data), data source (almost all studies used images 
rather than reports of these), image reader specialty 
(almost all studies had reporting by radiologists), and 
sample selection method (only one study randomly 
selected participants).21 We did not conduct subgroup 
analyses by age or sex (because we did not have 
individual participant data to allow meaningful 
comparisons), study country (because there was no 
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clear a priori reason for variation in prevalences of 
potentially serious incidental findings by country), 
or body region (because studies of brain and body 
MRI contributed data on different body regions from 
the same participants, violating the assumption that 
data within different subgroups are independent). We 
conducted subgroup analyses for brain and body MRI 
and region specific MRI for imaging setting (research 
v non-research) and for factors that might inform 
on risks of bias (blinding of readers to participant 
characteristics and number of image readers) where 
sufficient data allowed. There was no evidence of 
any clinically meaningful or statistically significant 
difference in prevalence of potentially serious 
incidental findings after the inclusion of subgroups as 
covariates (supplementary figures 3a-i, supplementary 
table 5).
Study specific reports of factors associated with 
potentially serious incidental findings
Eight studies reported factors associated with 
potentially serious incidental findings,25 27 29 30 34 36 39 42 
while a further five reported factors associated with 
incidental findings requiring follow-up, which we 
considered an approximate proxy for potentially 
serious incidental findings (supplementary tables 
6a-c).33 37 43 46 52 Two studies found significant 
associations between incidental findings requiring 
follow-up and increasing age,43 46 while another two 
found a consistently higher prevalence of incidental 
findings requiring follow-up33 and cavernomata39 in 
older age groups, although the increased prevalence was 
not statistically significant (supplementary table 6a). 
We saw no clear variation in prevalence of potentially 
serious incidental findings by sex (supplementary 
table 6b). Too few data were available on other factors 
(including medical history, symptoms, lifestyle factors, 
and genetics) to show any clear associations with 
potentially serious incidental findings (supplementary 
table 6c). No data were available on the associations 
between imaging sequence or reporter specialty with 
prevalence of potentially serious incidental findings.
Follow-up and final diagnoses
Only five studies systematically followed up and 
reported data on the final clinical diagnoses of selected 
subsets of participants with incidental findings (a 
total of 234 participants followed up), representing 
1.4% to 18.2% of all imaged participants in these 
studies (table 1).25-27 29 37 Summing arithmetically 
across these studies, only 48 of these 234 participants 
(that is, about one fifth) had clinically serious final 
diagnoses (although half had indeterminate final 
diagnoses, mostly from one study of brain MRI,29 in 
which participants were managed under “wait and 
see” policies). No study reported follow-up in a manner 
that enabled enumeration of the clinical assessments 
(eg, further imaging examinations, specialty referrals, 
biopsies) performed to clarify final diagnoses.
Discussion
Principal findings
We performed meta-analyses of published studies 
of the prevalence of potentially serious incidental 
findings among apparently asymptomatic adults 
undergoing MRI of the brain, thorax, abdomen, or brain 
and body. The pooled prevalence of potentially serious 
incidental findings was 3.9% on brain and body MRI 
(1.4% brain, 1.3% thorax, and 1.9% abdomen). After 
including incidental findings of uncertain potential 
seriousness, pooled prevalence increased to 12.8% 
(1.7% brain, 3.0% thorax, and 4.5% abdomen). We 
saw wide variation among studies in their prevalence 
estimates, probably reflecting variation between 
studies in participants’ characteristics, imaging 
setting, sample selection methods, and methods of 
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Fig 1 | Forest plots of prevalence per study and pooled prevalence estimates of 
potentially serious incidental findings and of potentially serious incidental findings 
plus indeterminate incidental findings, detected on magnetic resonance imaging (MRI) 
of the brain. T2=estimate of between-study variance on the logit scale (0 indicates 
no variance, increasing values indicate increasing heterogeneity). Solid squares and 
diamonds=point prevalence per study and pooled prevalence estimate of potentially 
serious incidental findings on brain MRI; white squares and diamonds=sensitivity 
analyses that include incidental findings classified as indeterminate in the point 
prevalence per study and pooled prevalence estimate of potentially serious incidental 
findings on brain MRI. Details of types and numbers of potentially serious incidental 
findings are provided in figure 3 and supplementary table 4a, while details of 
indeterminate findings are available online.13 *138 vascular incidental findings 
detected in six studies that used MR angiography24 31-34 38 were excluded from pooled 
analyses
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detecting incidental findings, as well as the challenges 
of applying a consistent definition of potentially 
serious incidental findings to the available descriptions 
of incidental findings in published papers. Suspected 
malignant incidental findings accounted for around 
half of all potentially serious incidental findings on 
brain, thoracic, abdominal, and brain and body MRI 
(0.6%, 0.6%, 1.3%, and 2.3% respectively). The very 
limited systematic follow-up data available (mainly 
from brain MRI studies) show that only about one fifth 
of people with a potentially serious incidental finding 
had a serious final clinical diagnosis.
Strengths and limitations of this study
By including all identified published data on the 
prevalence of potentially serious incidental findings on 
brain, thoracic, abdominal, and brain and body MRI, 
and by applying a consistent definition of potentially 
serious incidental findings across studies, we have 
provided important data on the prevalence of those 
incidental findings that may have an important impact 
on health. This review includes data on potentially 
serious incidental findings from different body regions, 
enabling comparisons of prevalence between regions. 
As such, our results can inform people undergoing (or 
staff conducting) brain and body MRI or region specific 
MRI in apparently asymptomatic adult volunteers. 
As most studies selected apparently asymptomatic 
populations, our results can apply directly to imaging 
performed for research and non-research settings such 
as screening.
Although we have not shown evidence of a statistically 
significant difference in the prevalence of potentially 
serious incidental findings between body regions, 
the pooled point prevalences were generally higher 
on abdomen MRI and on brain and body MRI than on 
brain or thorax MRI, particularly when indeterminate 
findings were included in sensitivity analyses. This 
pattern is biologically plausible and has been seen in 
data from primary studies.21 25 26 28 53 The heterogeneity 
between included studies, relative rarity of potentially 
serious incidental findings, methods of meta-
analyses, and conservative calculation of confidence 
intervals could have obscured true differences in the 
prevalence of potentially serious incidental findings 
between regions. Results on incidental findings from 
ongoing imaging studies based on large populations 
(including the UK Biobank imaging substudy, which 
by late October 2018 had imaged more than 30 000 of 
an intended 100 000 participants) should be able to 
confirm or refute this pattern in future.5 14 54 55
We found no evidence of any meaningful 
differences in the prevalence of potentially serious 
incidental findings between studies conducted in 
research or imaging settings for any body region, or 
between studies using readers blinded to participant 
characteristics versus not blinded or not stated, or for 
brain MRI studies using one reader versus more than 
one reader. Further subgroup analyses that could 
inform on factors influencing variation in prevalence 
in different body regions were limited, as data on 
relevant variables were either lacking for a large subset 
of studies, or resulted in very imbalanced subgroups.
Data were included in the review after screening and 
extraction by one author, rather than multiple authors. 
Although this method could limit the accuracy of the 
data extraction, it is unlikely to have substantially 
affected our results given the good agreement with a 
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Fig 2 | Forest plots of prevalence per study and pooled prevalence estimates of 
potentially serious incidental findings and of potentially serious incidental findings 
plus indeterminate incidental findings, detected on magnetic resonance imaging 
(MRI) of the thorax, abdomen, and brain and body (that is, brain, thorax, and abdomen 
combined). T2=estimate of between-study variance on the logit scale (0 indicates 
no variance, increasing values indicate increasing heterogeneity). Solid squares and 
diamonds=point prevalence per study and pooled prevalence estimate of potentially 
serious incidental findings on thoracic, abdominal, and brain and body MRI; white 
squares and diamonds=sensitivity analyses that include incidental findings classified 
as indeterminate in the point prevalence per study and pooled prevalence estimate of 
potentially serious incidental findings on thoracic, abdominal, and brain and body MRI. 
Details of types and numbers of potentially serious incidental findings are provided 
in figure 3 and supplementary tables 4b-c, while details of indeterminate findings are 
available online.13 *200 incidental findings detected in studies that used specialist 
imaging sequences (97 breast lesions in a study including magnetic resonance 
mammography,21 87 colonic polyps in two studies including magnetic resonance 
colonography,22 24 15 vascular findings such as stenosis or plaque in four studies 
including magnetic resonance angiography,21 22 24 28 and one myocardial infarction in a 
study including post-contrast cardiac imaging24) were excluded from pooled analyses
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second reviewer on a 10% subset of the studies. Owing 
to the lack of data on participants with more than 
one potentially serious incidental finding, prevalence 
estimates were based on the assumption that only 
one potentially serious incidental finding occurs per 
participant. However, it is unlikely that a substantial 
proportion of participants had more than one 
potentially serious incidental finding. The prevalence 
of incidental findings deemed “potentially serious” 
could vary with opinion and over time as evidence of 
their natural history accrues.
We could not explore the influence of technical 
imaging factors (eg, image resolution, magnet 
strength) on the prevalence of potentially serious 
incidental findings, because of limited data availability 
and reporting consistency, but these are unlikely 
to substantially influence the detection of the most 
common potentially serious incidental findings 
(suspected malignancies and aneurysms). The vast 
majority of included studies involved systematic 
radiologist reviews of images to detect incidental 
findings. No study directly compared radiologist 
readers with non-radiologist readers, although other 
policies to detect incidental findings might produce 
different results, such as radiographers flagging any 
concerning examinations for a radiologist to review.55
Comparison with other studies
A recent umbrella review of incidental findings arising 
from a range of imaging modalities (including MRI) 
found no existing systematic reviews of the prevalence 
of incidental findings in apparently asymptomatic 
volunteers on cardiac, abdominal, or brain and body 
MRI for comparison with our findings.56
Our update of an existing systematic review by 
Morris and colleagues8 of incidental findings on 
brain MRI resulted in similar prevalence of suspected 
malignant incidental findings. In the recent umbrella 
review mentioned above, researchers reported a 
prevalence of incidental findings on brain MRI of 
22% (95% confidence interval 14% to 31%), about 
10 times higher than our pooled prevalence estimate 
for brain MRI.8 56 57 Most of this difference is likely 
to be due to the umbrella review’s inclusion of all 
reported incidental findings, regardless of their 
potential clinical significance, whereas we focused 
on potentially serious incidental findings. Some of 
the difference might also be due to different study 
inclusion criteria (reflecting the different focus of the 
umbrella review, which had broader inclusion criteria, 
including studies of patients as well as apparently 
asymptomatic people), as well as a difference in meta-
analytical methods. Prevalence data, as proportions, 
will have a binomial distribution. The umbrella review 
used an arcsine transformation in its analyses of 
prevalence data, which avoids the challenge of directly 
modelling binomial data, whereas we used an exact 
method, which models the within-study variance as 
binomial to generate unbiased estimates.16
The recent umbrella review also reported far more 
final diagnosis data from studies derived from Morris 
and colleagues than we have in the present study.56 
To calculate the proportion of incidental findings 
resulting in known final diagnoses, the participants 
who form the denominator should all undergo 
systematic follow-up in order to generate an accurate 
numerator. We therefore scrutinised reports of all our 
included studies and found that only five reported such 
systematic methods; we did not consider diagnosis 
data from other studies to be robust, because they 
could represent suspected diagnoses rather than final 
diagnoses.
Implications of this study
Apparently asymptomatic people might undergo 
brain and body MRI by participating in research, or 
access non-research MRI via referral from a doctor28 or 
directly28 32 33 (eg, as part of occupational screening,31 
private health insurance,23 or company healthcare 
programmes24 28). Our prevalence data could be used 
to inform consent for MRI in both research and non-
research settings. Such data could also help researchers 
calculate anticipated numbers of participants with 
potentially serious incidental findings in future 
studies, to inform the design of appropriate incidental 
findings handling policies.
Our review highlights the limited data available on 
the follow-up and final diagnoses of potentially serious 
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Fig 3 | Numbers and types of potentially serious incidental findings on magnetic 
resonance imaging (MRI), by body region. Further details of the types of potentially 
serious incidental findings are provided in supplementary tables 4a-c. Potentially 
serious incidental findings were further classified as suspected malignancy (eg, 
masses), possible indicators of malignancy (incidental findings that were not masses, 
but could be related to malignancy, such as pleural effusions), or non-malignant 
(supplementary methods 3). In this figure, potentially serious incidental findings that 
were not suspected malignancies, possible indicators of malignancies, or suspected 
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incidental findings. Such data would inform judgments 
about the benefits versus harms of feeding back 
potentially serious incidental findings, which warrants 
further investigation with systematic, long term follow-
up of participants with these findings. Unlike public 
health screening programmes, which fulfill specific 
criteria to ensure net benefit,58 identification of a 
potentially serious incidental finding does not always 
lead to detection of disease at a stage where intervention 
will confer benefit. Many potentially serious incidental 
findings will turn out to be clinically non-serious, but 
require potentially anxiety provoking follow-up and 
potentially uncomfortable or harmful investigations 
to discover this. Even for those potentially serious 
incidental findings that do turn out to be clinically 
serious, for most there is no clear evidence base to 
inform decisions about treatment, and early treatment 
of some disorders might confer harm.59 Our prevalence 
data could inform power calculations for future clinical 
trials of conservative or active treatments of potentially 
serious incidental findings, in order to develop good 
medical practices that minimise harm to people with 
potentially serious incidental findings, and ensure 
appropriate use of health services.
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Table 1 | Methods used to follow up 234 people with potentially serious incidental findings and severity of final diagnoses
Study variables Methods of follow-up of incidental findings Severity of final diagnoses (No)
First author 
surname and year 
of publication
Imaged 
body 
regions
No of participants 
followed up/total 
No imaged (%)
Subset of participants 
followed up* Data type (source)
Duration of 
follow-up Serious Non-serious Indeterminate
Bos 201629 Brain 188/5800 (3.2) Those with an incidental 
finding who were referred to 
specialists†
Clinical management 
(medical records)
Until last clinical 
follow-up or 
death
39 34 115
Sandeman 201337 Brain 10/700 (1.4) Those with an incidental 
finding who were referred to 
family doctors‡
Resulting action (medical 
records)
Not specified 5 5 0
Morin 200925 Brain and 
body
5/148 (3.4) Those with highly significant 
findings§
Investigations and 
treatments (contact with 
general practitioner or 
participant)
Not specified 0 3 2
Lo 200826 Brain and 
body
24/132 (18.2) Those with an incidental 
finding that required further 
investigation¶
Not specified Not specified 4 20 0
Saya 201727 Brain and 
body
7/44 (15.9) Those with incidental 
findings deemed to require 
follow-up**
Investigations (not 
specified)
Not specified 0 7 0
Total No (% of 234 followed up) Not applicable Not applicable Not applicable 69(29.5) 117(50)
*This group could be considered a study specific proxy for potentially serious incidental findings but is not identical to the consistent definition applied in the present study. Hence study specific 
numbers in this table differ from study specific numbers of potentially serious incidental findings in meta-analyses.
†Decision for referral depended on the incidental finding and consultation with clinicians.
‡Decision for referral depended on discussion between radiologists and a geriatrician and other clinicians as necessary.
§Highly significant findings were defined as requiring prompt medical follow-up, such as indeterminate masses in solid organs, enlarged lymph nodes and ovarian masses or cysts, as judged by 
consensus of two radiologists. Participants’ family doctors were informed of the finding.
¶Definition of incidental findings requiring further investigation, or processes for judging this are not reported.
**As determined by study radiologists, follow-up was discussed by a multidisciplinary team including principal investigators, radiologists, and other study staff (not otherwise specified).
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important aspects of the study have been omitted; and that any 
discrepancies from the study as planned (and, if relevant, registered) 
have been explained.
This is an Open Access article distributed in accordance with the 
terms of the Creative Commons Attribution (CC BY 4.0) license, which 
permits others to distribute, remix, adapt and build upon this work, 
for commercial use, provided the original work is properly cited. See: 
http://creativecommons.org/licenses/by/4.0/.
1 Post W. The multi-ethnic study of atherosclerosis. https://www.
hopkinsmedicine.org/heart_vascular_institute/clinical_trials/
preventive/mesa.html.
2 Icelandic Heart Association. About the Icelandic Heart Association. 
https://www.hjartarannsokn.is/index.aspx?GroupId=406.
3 Ikram MA, van der Lugt A, Niessen WJ, et al. The Rotterdam 
Scan Study: design update 2016 and main findings. Eur J 
Epidemiol 2015;30:1299-315. doi:10.1007/s10654-015-0105-7 
4 Nationale Kohorte. NAKO. http://nako.de/.
5 Biobank UK. UK Biobank imaging study. 2014. https://imaging.
ukbiobank.ac.uk/.
6 Wolf SM, Lawrenz FP, Nelson CA, et al. Managing incidental findings 
in human subjects research: analysis and recommendations. J 
Law Med Ethics 2008;36:219-48, 211. doi:10.1111/j.1748-
720X.2008.00266.x 
7 Medical Research Council. Wellcome Trust. Framework on the 
feedback of health-related findings in research. 2014. https://www.
mrc.ac.uk/documents/pdf/mrc-wellcome-trust-framework-on-the-
feedback-of-health-related-findings-in-researchpdf/.
8 Morris Z, Whiteley WN, Longstreth WT Jr, et al. Incidental findings on 
brain magnetic resonance imaging: systematic review and meta-
analysis. BMJ 2009;339:b3016. doi:10.1136/bmj.b3016 
9 Dunet V, Schwitter J, Meuli R, Beigelman-Aubry C. Incidental 
extracardiac findings on cardiac MR: Systematic review and meta-
analysis. J Magn Reson Imaging 2016;43:929-39. doi:10.1002/
jmri.25053 
10 Jacobs PC, Mali WP, Grobbee DE, van der Graaf Y. Prevalence of 
incidental findings in computed tomographic screening of the chest: 
a systematic review. J Comput Assist Tomogr 2008;32:214-21. 
doi:10.1097/RCT.0b013e3181585ff2 
11 Petersen SE, Matthews PM, Bamberg F, et al. Imaging in population 
science: cardiovascular magnetic resonance in 100,000 participants 
of UK Biobank - rationale, challenges and approaches. J Cardiovasc 
Magn Reson 2013;15:46-46. doi:10.1186/1532-429X-15-46 
12 Gibson L, Paul L, Wardlaw J, et al. Potentially serious incidental 
findings on brain and body magnetic resonance imaging 
conducted among apparently healthy adults: a systematic review. 
2016. http://www.crd.york.ac.uk/PROSPERO/display_record.
asp?ID=CRD42016029472.
13 Gibson L, Paul L, Sudlow CLM. Potentially serious incidental 
findings on brain and body magnetic resonance imaging conducted 
among apparently healthy adults: a systematic review and meta-
analysis. 2017. doi:10.7488/ds/2100.
14 Bertheau RC, von Stackelberg O, Weckbach S, et al. Management of 
incidental findings in the German National Cohort. In: Weckbach S, 
ed. Radiological incidental findings. Springer, 2017: 57-70.
15 Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic 
introduction to fixed-effect and random-effects models for meta-
analysis. Res Synth Methods 2010;1:97-111. doi:10.1002/jrsm.12 
16 Hamza TH, van Houwelingen HC, Stijnen T. The binomial distribution 
of meta-analysis was preferred to model within-study variability. J Clin 
Epidemiol 2008;61:41-51. doi:10.1016/j.jclinepi.2007.03.016 
17 Riley RD, Higgins JPT, Deeks JJ. Interpretation of random effects meta-
analyses. BMJ 2011;342:d549. doi:10.1136/bmj.d549 
18 Petitti DB. Approaches to heterogeneity in meta-analysis. Stat 
Med 2001;20:3625-33. doi:10.1002/sim.1091 
19 Hunter JP, Saratzis A, Sutton AJ, Boucher RH, Sayers RD, Bown MJ. 
In meta-analyses of proportion studies, funnel plots were found 
to be an inaccurate method of assessing publication bias. J Clin 
Epidemiol 2014;67:897-903. doi:10.1016/j.jclinepi.2014.03.003 
20 Bland M. Meta-analysis: publication bias. 2006. https://www-users.
york.ac.uk/~mb55/msc/systrev/week7/pub_text.pdf.
21 Hegenscheid K, Seipel R, Schmidt CO, et al. Potentially relevant 
incidental findings on research whole-body MRI in the general adult 
population: frequencies and management. Eur Radiol 2013;23:816-
26. doi:10.1007/s00330-012-2636-6 
22 Baumgart D, Egelhof T. [Preventive whole-body screening 
encompassing modern imaging using magnetic resonance 
tomography]. Herz 2007;32:387-94. doi:10.1007/s00059-007-
3020-1 
23 Cieszanowski A, Maj E, Kulisiewicz P, et al. Non-contrast-enhanced 
whole-body magnetic resonance imaging in the general population: 
the incidence of abnormal findings in patients 50 years old and 
younger compared to older subjects. PLoS One 2014;9:e107840. 
doi:10.1371/journal.pone.0107840 
24 Goehde SC, Hunold P, Vogt FM, et al. Full-body cardiovascular and 
tumor MRI for early detection of disease: feasibility and initial 
experience in 298 subjects. AJR Am J Roentgenol 2005;184:598-
611. doi:10.2214/ajr.184.2.01840598 
25 Morin SHX, Cobbold JFL, Lim AKP, et al. Incidental findings in 
healthy control research subjects using whole-body MRI. Eur J 
Radiol 2009;72:529-33. doi:10.1016/j.ejrad.2008.08.006 
26 Lo GG, Ai V, Au-Yeung KM, Chan JK, Li KW, Chien D. Magnetic 
resonance whole body imaging at 3 Tesla: feasibility and findings 
in a cohort of asymptomatic medical doctors. Hong Kong Med 
J 2008;14:90-6.
27 Saya S, Killick E, Thomas S, et al, SIGNIFY Study Steering Committee. 
Baseline results from the UK SIGNIFY study: a whole-body MRI 
screening study in TP53 mutation carriers and matched controls. Fam 
Cancer 2017;16:433-40. doi:10.1007/s10689-017-9965-1 
28 Tarnoki DL, Tarnoki AD, Richter A, Karlinger K, Berczi V, Pickuth D. 
Clinical value of whole-body magnetic resonance imaging in health 
screening of general adult population. Radiol Oncol 2015;49:10-6. 
doi:10.2478/raon-2014-0031 
29 Bos D, Poels MMF, Adams HHH, et al. Prevalence, clinical 
management, and natural course of incidental findings on 
brain MR images: the population-based Rotterdam Scan Study. 
Radiology 2016;281:507-15. doi:10.1148/radiol.2016160218 
30 Yue NC, Longstreth WTJr, Elster AD, Jungreis CA, O’Leary DH, Poirier 
VC. Clinically serious abnormalities found incidentally at MR 
imaging of the brain: data from the Cardiovascular Health Study. 
Radiology 1997;202:41-6. doi:10.1148/radiology.202.1.8988190 
31 Weber F, Knopf H. Incidental findings in magnetic resonance imaging 
of the brains of healthy young men. J Neurol Sci 2006;240:81-4. 
doi:10.1016/j.jns.2005.09.008 
32 Lee WJ, Chang LB, Lee YC. Incidental findings on brain MRI. N 
Engl J Med 2008;358:853-4, author reply 854-5. doi:10.1056/
NEJMc073320 
33 Tsushima Y, Taketomi-Takahashi A, Endo K. Prevalence of abnormal 
findings on brain magnetic resonance (MR) examinations in 
adult participants of brain docking. BMC Neurol 2005;5:18. 
doi:10.1186/1471-2377-5-18 
34 Håberg AK, Hammer TA, Kvistad KA, et al. Incidental intracranial 
findings and their clinical impact: the HUNT MRI study in a general 
population of 1006 participants between 50-66 years. PLoS 
One 2016;11:e0151080. doi:10.1371/journal.pone.0151080 
35 Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain 
magnetic resonance imaging from 1000 asymptomatic volunteers. 
JAMA 1999;282:36-9. doi:10.1001/jama.282.1.36 
36 Sommer IE, de Kort GA, Meijering AL, et al. How frequent are 
radiological abnormalities in patients with psychosis? A review of 
1379 MRI scans. Schizophr Bull 2013;39:815-9. doi:10.1093/
schbul/sbs037 
37 Sandeman EM, Hernandez MdelC, Morris Z, et al. Incidental findings 
on brain MR imaging in older community-dwelling subjects are 
common but serious medical consequences are rare: a cohort study. 
PLoS One 2013;8:e71467. doi:10.1371/journal.pone.0071467 
38 Alphs HH, Schwartz BS, Stewart WF, Yousem DM. Findings on 
brain MRI from research studies of occupational exposure to 
known neurotoxicants. AJR Am J Roentgenol 2006;187:1043-7. 
doi:10.2214/AJR.05.0421 
39 Brugulat-Serrat A, Rojas S, Bargalló N, et al. Incidental findings on 
brain MRI of cognitively normal first-degree descendants of patients 
with Alzheimer’s disease: a cross-sectional analysis from the ALFA 
(Alzheimer and Families) project. BMJ Open 2017;7:e013215. 
doi:10.1136/bmjopen-2016-013215 
40 Hoggard N, Darwent G, Capener D, Wilkinson ID, Griffiths PD. The 
high incidence and bioethics of findings on magnetic resonance 
brain imaging of normal volunteers for neuroscience research. J Med 
Ethics 2009;35:194-9. doi:10.1136/jme.2008.025502 
41 Boutet C, Vassal F, Celle S, et al. Incidental findings on brain magnetic 
resonance imaging in the elderly: the PROOF study. Brain Imaging 
Behav 2017;11:293-9. doi:10.1007/s11682-016-9519-4 
42 Kumar R, Sachdev PS, Price JL, Rosenman S, Christensen H. Incidental 
brain MRI abnormalities in 60- to 64-year-old community-dwelling 
individuals: data from the Personality and Total Health Through Life 
study. Acta Neuropsychiatr 2008;20:87-90. doi:10.1111/j.1601-
5215.2008.00273.x 
43 Hartwigsen G, Siebner HR, Deuschl G, Jansen O, Ulmer S. 
Incidental findings are frequent in young healthy individuals 
undergoing magnetic resonance imaging in brain research 
imaging studies: a prospective single-center study. J Comput Assist 
Tomogr 2010;34:596-600. doi:10.1097/RCT.0b013e3181d9c2bb 
44 Reneman L, de Win MM, Booij J, et al. Incidental head and neck 
findings on MRI in young healthy volunteers: prevalence and clinical 
implications. AJNR Am J Neuroradiol 2012;33:1971-4. doi:10.3174/
ajnr.A3217 
45 Li WC, Tu CH, Chao HT, Yeh TC, Chen LF, Hsieh JC. High prevalence 
of incidental brain findings in primary dysmenorrhoea. Eur J 
Pain 2015;19:1071-4. doi:10.1002/ejp.639 
 o
n
 27 N
ovem
ber 2018 by guest. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.k4577 on 22 November 2018. Downloaded from 
RESEARCH
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
46 Illes J, Rosen AC, Huang L, et al. Ethical consideration of  
incidental findings on adult brain MRI in research. 
Neurology 2004;62:888-90. doi:10.1212/01.
WNL.0000118531.90418.89 
47 Wahlund LO, Agartz I, Sääf J, Wetterberg L, Marions O. [Magnetic 
resonance tomography in psychiatry—clear benefits for health care 
services]. Lakartidningen 1989;86:3991-4.
48 Menzler K, Iwinska-Zelder J, Shiratori K, et al. Evaluation of MRI 
criteria (1.5 T) for the diagnosis of hippocampal sclerosis in 
healthy subjects. Epilepsy Res 2010;89:349-54. doi:10.1016/j.
eplepsyres.2010.02.010 
49 Lubman DI, Velakoulis D, McGorry PD, et al. Incidental 
radiological findings on brain magnetic resonance imaging in 
first-episode psychosis and chronic schizophrenia. Acta Psychiatr 
Scand 2002;106:331-6. doi:10.1034/j.1600-0447.2002.02217.x 
50 Trufyn J, Hill MD, Scott JN, et al. The prevalence of incidental findings 
in multiple sclerosis patients. Can J Neurol Sci 2014;41:49-52. 
doi:10.1017/S0317167100016255 
51 Vogel-Claussen J, Li D, Carr J, et al. Extracoronary abnormalities 
on coronary magnetic resonance angiography in the multiethnic 
study of atherosclerosis study: frequency and clinical significance. 
J Comput Assist Tomogr 2009;33:752-4. doi:10.1097/
RCT.0b013e318196bf2e 
52 Loy A, Morgan R, O’Dea S, Daly C, Mulcahy F. Clinically significant 
extra-cardiac findings in asymptomatic HIV-positive men undergoing 
cardiac magnetic resonance imaging. Int J STD AIDS 2015;26:346-
51. doi:10.1177/0956462414538005 
53 Gibson LM, Littlejohns TJ, Adamska L, et al, UK Biobank 
Imaging Working Group. Impact of detecting potentially serious 
incidental findings during multi-modal imaging. Wellcome Open 
Res 2017;2:114. doi:10.12688/wellcomeopenres.13181.1 
54 German National Cohort (GNC) Consortium. The German 
National Cohort: aims, study design and organization. Eur J 
Epidemiol 2014;29:371-82. doi:10.1007/s10654-014-9890-7 
55 Gibson LM, Sellors J, Sudlow CLM. Management of incidental findings 
on multimodal imaging in UK Biobank. In: Weckbach S, ed. Incidental 
radiological findings. Springer, 2016: 71-810.1007/174_2016_91.
56 O’Sullivan JW, Muntinga T, Grigg S, Ioannidis JPA. Prevalence 
and outcomes of incidental imaging findings: umbrella review. 
BMJ 2018;361:k2387. doi:10.1136/bmj.k2387 
57 Takashima K, Takimoto Y, Nakazawa E, et al. Discovery and informing 
research participants of incidental findings detected in brain 
magnetic resonance imaging studies: Review and multi-institutional 
study. Brain Behav 2017;7:e00676. doi:10.1002/brb3.676 
58 Wilson JMG, Jungner YG. [Principles and practice of mass screening 
for disease]. Bol Oficina Sanit Panam 1968;65:281-393.
59 Mohr JP, Parides MK, Stapf C, et al, international ARUBA investigators. 
Medical management with or without interventional therapy 
for unruptured brain arteriovenous malformations (ARUBA): a 
multicentre, non-blinded, randomised trial. Lancet 2014;383:614-
21. doi:10.1016/S0140-6736(13)62302-8
Web appendix: Supplement
 o
n
 27 N
ovem
ber 2018 by guest. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.k4577 on 22 November 2018. Downloaded from 
